Is the PARADIGM-HF cohort representative of the real-world heart failure patient population?

Is the PARADIGM-HF cohort representative of the real-world heart failure patient population?

Introduction: A new drug with prognostic impact on heart failure, sacubitril/valsartan, has been introduced in current guidelines. However, randomized trial results can be compromised by lack of representativeness. We aimed to assess the representativeness of the PARADIGM-HF trial in a real-world po...

Full description

Bibliographic Details
Main Authors: Gustavo Rodrigues, António Tralhão, Carlos Aguiar, Pedro Freitas, António Ventosa, Miguel Mendes
Format: Article
Language:English
Published: Elsevier 2018-06-01
Series:Revista Portuguesa de Cardiologia
Online Access:http://www.sciencedirect.com/science/article/pii/S0870255117302068

Internet

http://www.sciencedirect.com/science/article/pii/S0870255117302068

Similar Items